DOJ plans to move to reschedule marijuana as a lower-risk drug

The Biden administration plans to reclassify marijuana as a lower-risk substance, acknowledging its medical benefits and impacting cannabis-related research and industry. The US Department of Justice is expected to recommend rescheduling marijuana as a Schedule III controlled substance, along with prescription drugs like ketamine and Tylenol with codeine. The reclassification process will involve submitting a draft rule to the White House Office of Management and Budget and will go through a public comment period. Currently categorized as a Schedule I drug, marijuana would no longer be subject to the strictest restrictions if the reclassification occurs.